Susan M. Pullen

1.2k total citations
25 papers, 953 citations indexed

About

Susan M. Pullen is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Susan M. Pullen has authored 25 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Organic Chemistry and 9 papers in Cancer Research. Recurrent topics in Susan M. Pullen's work include Cancer, Hypoxia, and Metabolism (9 papers), Synthesis and Biological Evaluation (7 papers) and Click Chemistry and Applications (5 papers). Susan M. Pullen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Synthesis and Biological Evaluation (7 papers) and Click Chemistry and Applications (5 papers). Susan M. Pullen collaborates with scholars based in New Zealand, United States and United Kingdom. Susan M. Pullen's co-authors include William R. Wilson, William A. Denny, Adam V. Patterson, Kevin O. Hicks, Dianne M. Ferry, Nuala A. Helsby, Graham J. Atwell, Brian D. Palmer, William Wilson and Rachelle S. Singleton and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Susan M. Pullen

25 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan M. Pullen New Zealand	19	528	346	248	191	190	25	953
Kanami Yamazaki Japan	17	892 1.7×	203 0.6×	238 1.0×	62 0.3×	334 1.8×	27	1.4k
Philip G. Penketh United States	24	814 1.5×	299 0.9×	304 1.2×	58 0.3×	190 1.0×	60	1.3k
Shangjin Yang New Zealand	12	277 0.5×	174 0.5×	161 0.6×	96 0.5×	79 0.4×	21	520
Dianne M. Ferry New Zealand	10	263 0.5×	203 0.6×	85 0.3×	89 0.5×	121 0.6×	12	562
G.E. Adams United Kingdom	14	345 0.7×	327 0.9×	170 0.7×	62 0.3×	134 0.7×	35	894
Krishnamurthy Shyam United States	21	602 1.1×	257 0.7×	231 0.9×	44 0.2×	139 0.7×	46	937
Moana Tercel New Zealand	22	570 1.1×	269 0.8×	475 1.9×	66 0.3×	224 1.2×	52	1.0k
Roger G. Melton United Kingdom	18	882 1.7×	70 0.2×	239 1.0×	276 1.4×	309 1.6×	31	1.3k
Liang Xiong China	6	626 1.2×	143 0.4×	191 0.8×	40 0.2×	307 1.6×	10	1.1k
Miriam A. Stephens United Kingdom	15	686 1.3×	290 0.8×	209 0.8×	34 0.2×	268 1.4×	27	1.1k

Countries citing papers authored by Susan M. Pullen

Since Specialization

Citations

This map shows the geographic impact of Susan M. Pullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Pullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Pullen more than expected).

Fields of papers citing papers by Susan M. Pullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Pullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Pullen. The network helps show where Susan M. Pullen may publish in the future.

Co-authorship network of co-authors of Susan M. Pullen

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Pullen. A scholar is included among the top collaborators of Susan M. Pullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Pullen. Susan M. Pullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abbattista, Maria R., Stephen M. F. Jamieson, Yongchuan Gu, et al.. (2015). Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma. Cancer Biology & Therapy. 16(4). 610–622. 27 indexed citations

Hunter, Francis W., et al.. (2014). Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 13(11). 2501–2514. 35 indexed citations

Jamieson, Stephen M. F., Yongchuan Gu, Duohui Jing, et al.. (2014). A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells. Biochemical Pharmacology. 88(1). 36–45. 29 indexed citations

Singleton, Rachelle S., Christopher P. Guise, Dianne M. Ferry, et al.. (2009). DNA Cross-Links in Human Tumor Cells Exposed to the Prodrug PR-104A: Relationships to Hypoxia, Bioreductive Metabolism, and Cytotoxicity. Cancer Research. 69(9). 3884–3891. 60 indexed citations

Wilson, William R., Kevin O. Hicks, Susan M. Pullen, et al.. (2007). Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards. Radiation Research. 167(6). 625–636. 53 indexed citations

Patterson, Adam V., Dianne M. Ferry, Shelley J. Edmunds, et al.. (2007). Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104. Clinical Cancer Research. 13(13). 3922–3932. 186 indexed citations

Atwell, Graham J., Shangjin Yang, Frederik B. Pruijn, et al.. (2007). Synthesis and Structure−Activity Relationships for 2,4-Dinitrobenzamide-5-mustards as Prodrugs for the Escherichia coli nfsB Nitroreductase in Gene Therapy. Journal of Medicinal Chemistry. 50(6). 1197–1212. 30 indexed citations

Helsby, Nuala A., et al.. (2004). 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT. British Journal of Cancer. 90(5). 1084–1092. 66 indexed citations

Wilson, William R., Susan M. Pullen, Alison Hogg, et al.. (2004). In Vitro and In Vivo Models for Evaluation of GDEPT: Quantifying Bystander Killing in Cell Cultures and Tumors. Humana Press eBooks. 90. 403–432. 17 indexed citations

10.

Helsby, Nuala A., Graham J. Atwell, Shangjin Yang, et al.. (2004). Aziridinyldinitrobenzamides: Synthesis and Structure−Activity Relationships for Activation by E. coli Nitroreductase. Journal of Medicinal Chemistry. 47(12). 3295–3307. 27 indexed citations

11.

Tercel, Moana, Stephen M. Stribbling, Hilary M. Sheppard, et al.. (2003). Unsymmetrical DNA Cross-Linking Agents: Combination of the CBI and PBD Pharmacophores. Journal of Medicinal Chemistry. 46(11). 2132–2151. 54 indexed citations

12.

Hay, Michael P., Graham J. Atwell, William R. Wilson, Susan M. Pullen, & William A. Denny. (2003). Structure−Activity Relationships for 4-Nitrobenzyl Carbamates of 5-Aminobenz[e]indoline Minor Groove Alkylating Agents as Prodrugs for GDEPT in Conjunction with E. coli Nitroreductase. Journal of Medicinal Chemistry. 46(12). 2456–2466. 29 indexed citations

13.

Wilson, William R., Susan M. Pullen, Alison Hogg, et al.. (2002). Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.. PubMed. 62(5). 1425–32. 59 indexed citations

14.

Siim, Bronwyn G., et al.. (2000). Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Biochemical Pharmacology. 60(7). 969–978. 26 indexed citations

15.

Siim, Bronwyn G., Graham J. Atwell, Robert F. Anderson, et al.. (1997). Hypoxia-Selective Antitumor Agents. 15. Modification of Rate of Nitroreduction and Extent of Lysosomal Uptake by Polysubstitution of 4-(Alkylamino)-5-nitroquinoline Bioreductive Drugs. Journal of Medicinal Chemistry. 40(9). 1381–1390. 15 indexed citations

16.

Wilson, William R., et al.. (1996). Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.. PubMed. 27. S43–7. 31 indexed citations

17.

Atwell, Graham J., Maruta Boyd, Brian D. Palmer, et al.. (1996). Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase.. PubMed. 11(7). 553–67. 11 indexed citations

18.

Lee, Ho H., William R. Wilson, Dianne M. Ferry, et al.. (1996). Hypoxia-Selective Antitumor Agents. 13. Effects of Acridine Substitution on the Hypoxia-Selective Cytotoxicity and Metabolic Reduction of the Bis-bioreductive Agent Nitracrine N-Oxide. Journal of Medicinal Chemistry. 39(13). 2508–2517. 29 indexed citations

19.

Denny, William A., William R. Wilson, Moana Tercel, Pierre van Zijl, & Susan M. Pullen. (1994). Nitrobenzyl mustard quaternary salts: A new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction. International Journal of Radiation Oncology*Biology*Physics. 29(2). 317–321. 18 indexed citations

20.

Palmer, Brian D., William Wilson, Susan M. Pullen, & William A. Denny. (1990). Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. Journal of Medicinal Chemistry. 33(1). 112–121. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact